These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 10513728)
1. Are drugs within a class interchangeable? Furberg CD; Herrington DM; Psaty BM Lancet; 1999 Oct; 354(9185):1202-4. PubMed ID: 10513728 [No Abstract] [Full Text] [Related]
2. Rational formulary decision making: is drug classification rational? Berger ML Value Health; 2003; 6(2):175-6. PubMed ID: 12641868 [No Abstract] [Full Text] [Related]
3. What's current in U.S. drug regulation. Halperin JA Drug Inf J; 1978 OCt-Dec; 12(4):197-203. PubMed ID: 10316752 [No Abstract] [Full Text] [Related]
4. The clinical value of FDA class C drugs approved from 1981 to 1988. Yasuda SU; Woosley RL Clin Pharmacol Ther; 1992 Dec; 52(6):577-82. PubMed ID: 1458766 [No Abstract] [Full Text] [Related]
7. FDA moves closer to new requirements for NTI drugs. Traynor K Am J Health Syst Pharm; 2011 Sep; 68(17):1568-9, 1570. PubMed ID: 21856797 [No Abstract] [Full Text] [Related]
8. The FDA's classification system for new drugs. An evaluation of therapeutic gain. Finkel MJ N Engl J Med; 1980 Jan; 302(3):181-3. PubMed ID: 7350458 [No Abstract] [Full Text] [Related]
10. Adverse drug reactions: a review for healthcare practitioners. Young LR; Wurtzbacher JD; Blankenship CS Am J Manag Care; 1997 Dec; 3(12):1884-906; quiz 1909-10. PubMed ID: 10178476 [No Abstract] [Full Text] [Related]
11. Seven therapeutic categories account for most drug cost increases. Manag Care; 2011 Dec; 20(12):69. PubMed ID: 22259880 [No Abstract] [Full Text] [Related]
12. Review of the processes for FDA oversight of drugs, medical devices, and combination products. Sweet BV; Schwemm AK; Parsons DM J Manag Care Pharm; 2011; 17(1):40-50. PubMed ID: 21204589 [No Abstract] [Full Text] [Related]
13. Report of the Teratology Society Public Affairs Committee symposium on FDA classification of drugs. Friedman JM Teratology; 1993 Jul; 48(1):5-6. PubMed ID: 8102499 [No Abstract] [Full Text] [Related]
14. How good are our drugs? Miller LC Am J Hosp Pharm; 1970 May; 27(5):367-74. PubMed ID: 5422276 [No Abstract] [Full Text] [Related]
15. FDA new drug approvals in 2009. Wynn RL Gen Dent; 2010; 58(4):280-4. PubMed ID: 20591770 [No Abstract] [Full Text] [Related]
16. Pharmaceutical drugs-the good and the not so good: together, we can make it better. Campbell AW Altern Ther Health Med; 2014; 20(1):9-11. PubMed ID: 24445351 [No Abstract] [Full Text] [Related]
17. Determining drug equality. Hecht A FDA Consum; 1975 Nov; 9(9):18-20. PubMed ID: 10316633 [No Abstract] [Full Text] [Related]
18. The debate over substitution policy. Its evolution and scientific basis. Schwartz LL Am J Med; 1985 Aug; 79(2B):38-44. PubMed ID: 3898831 [TBL] [Abstract][Full Text] [Related]
19. Generic vs. brand name drugs--defining and enforcing standards. Lasagna LC Internist; 1979 May; 20(4):11, 13. PubMed ID: 10316827 [No Abstract] [Full Text] [Related]